EUVIMEDScopri EUVIMED
Open access · CC BY-NC 4.0

桂枝茯苓汤联合甲硝唑治疗子宫内膜炎的炎症因子水平变化及妊娠率分析

晓燕 杨

医学与健康科学研究 · 2026

DOI: 10.65196/n5pg3c55 ↗

At a glance

Journal article in 医学与健康科学研究, 2026. Written by 晓燕 杨. The full text is freely available (open access, CC BY-NC 4.0).

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Objective

This study aims to investigate the impact of Guizhi Fuling Decoction combined with metronidazole on the level of the inflammatory factor CD138 in the treatment of endometritis and its improvement effect on the pregnancy rate.

Methods

A total of 50 patients with endometritis treated from March 2020 to March 2022 were selected and divided into an experimental group (treated with Guizhi Fuling Decoction combined with metronidazole) and a control group (treated with metronidazole alone) according to the treatment plan. The changes in the inflammatory factor CD138 before and after treatment were detected, and the improvement in the pregnancy rate was analyzed.

Results

The level of the inflammatory factor CD138 in the combined treatment group significantly decreased, and the pregnancy rate was significantly higher than that in the control group.

Conclusion

The treatment of endometritis with Guizhi Fuling Decoction combined with metronidazole can effectively reduce the CD138 level and improve the pregnancy rate of patients, which is worthy of clinical promotion.

Cite

APA

杨, 晓. (2026). 桂枝茯苓汤联合甲硝唑治疗子宫内膜炎的炎症因子水平变化及妊娠率分析. 医学与健康科学研究. https://doi.org/10.65196/n5pg3c55

Vancouver

杨 晓. 桂枝茯苓汤联合甲硝唑治疗子宫内膜炎的炎症因子水平变化及妊娠率分析. 医学与健康科学研究. 2026. doi:10.65196/n5pg3c55

BibTeX
@article{2026,
  author = {杨, 晓燕},
  title = {桂枝茯苓汤联合甲硝唑治疗子宫内膜炎的炎症因子水平变化及妊娠率分析},
  journal = {医学与健康科学研究},
  year = {2026},
  doi = {10.65196/n5pg3c55}
}
Start for free →